Company: HUM
Filing Date: 2025-03-26
Form Type: 424B5
Source: 0001628280-25-014916
Chunk: 11

Company: HUMANA INC
Filing Date: 2025-03-26
Form: 424B5
Chunk 11
---
 |    |
| Retained earnings                                                                           |     |                   |  28,317 |     |             |     |   |    |
| Accumulated other comprehensive loss                                                        |     |                   |  -1,067 |     |             |     |   |    |
| Treasury stock, at cost, 78,077,195 shares                                                  |     |                   | -14,371 |     |             |     |   |    |
| Noncontrolling interests                                                                    |     |                   |      70 |     |             |     |   |    |
| Total equity                                                                                |     |                   |  16,445 |     |             |     |   |    |
| Total capitalization                                                                        |     | $                 |  28,166 |     |             |     | $ |    |

__________________

(1) Cash and cash equivalents include the net proceeds of the additional 20 notes offered hereby and the net proceeds of the 2035 Notes and the 2055 Notes issued on March 5, 2025 in excess of the amount required to repay the 4.500% Senior Notes due 2025 (the “2025 Notes”).

(2) Includes the 2025 Notes, which are classified as short-term debt because they mature in April 2025.

(3) The proceeds of the additional 20 notes offered hereby are presented net of approximately $ million of original issue discount and $ million related to debt issuance costs.

(4) Includes the 2035 Notes and the 2055 Notes, net of approximately $6.1 million of original issue discount and $13.1 million related to debt issuance costs.

(5) As of December 31, 2024, we had no borrowings outstanding under our Revolving Credit Facility or our 364-day Credit Facility and approximately $18 million of letters of credit outstanding under the Revolving Credit Facility. Accordingly, as of December 31, 2024, we had approximately $2.624 billion of remaining borrowing capacity under the Revolving Credit Facility and $2.1 billion of remaining borrowing capacity under the 364-day Credit Facility (which excludes an uncommitted $500 million of incremental loan facilities).

<div align='center'>S-6</div>

Table of Content s

### USE OF PROCEEDS
We estimate that our net proceeds from the issuance and sale of the additional 20 notes will be approximately $ , after deducting underwriters’ discounts and our estimated offering expenses. We intend